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A B S T R A C T
Introduction: Bone fractures fail to heal and form nonunions in roughly 5% of cases, with little expectation
of spontaneous healing thereafter. We present a systematic review and meta-analysis of published
papers that describe nonunions treated with low-intensity pulsed ultrasound (LIPUS).
Methods: Articles in PubMed, Ovid MEDLINE, CINAHL, AMED, EMBASE, Cochrane Library, and Scopus
databases were searched, using an approach recommended by the Methodological Index for Non-
Randomized Studies (MINORS), with a Level of Evidence rating by two reviewers independently. Studies
are included here if they reported fractures older than 3 months, presented new data with a sample
N  12, and reported fracture outcome (Heal/Fail).
Results: Thirteen eligible papers reporting LIPUS treatment of 1441 nonunions were evaluated. The
pooled estimate of effect size for heal rate was 82% (95% CI: 77–87%), for any anatomical site and fracture
age of at least 3 months, with statistical heterogeneity detected across all primary studies (Q = 41.2
(df = 12), p < 0.001, Tau2 = 0.006, I2 = 71). With a stricter deﬁnition of nonunion as fracture age of at least 8
months duration, the pooled estimate of effect size was 84% (95% CI: 77%–91.6%; heterogeneity present:
Q = 21 (df = 8), p < 0.001, Tau2 = 0.007, I2 = 62). Hypertrophic nonunions beneﬁtted more than biologically
inactive atrophic nonunions. An interval without surgery of <6 months prior to LIPUS was associated
with a more favorable result. Stratiﬁcation of nonunions by anatomical site revealed no statistically
signiﬁcant differences between upper and lower extremity long bone nonunions.
Conclusions: LIPUS treatment can be an alternative to surgery for established nonunions. Given that no
spontaneous healing of established nonunions is expected, and that it is challenging to test the efﬁcacy of
LIPUS for nonunion by randomized clinical trial, ﬁndings are compelling. LIPUS may be most useful in
patients for whom surgery is high risk, including elderly patients at risk of delirium, or patients with
dementia, extreme hypertension, extensive soft-tissue trauma, mechanical ventilation, metabolic
acidosis, multiple organ failure, or coma. With an overall average success rate for LIPUS >80% this is
comparable to the success of surgical treatment of non-infected nonunions.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Bone fractures fail to heal and become nonunion in roughly 5%
of patients [1]. Nonunions have no expectation of spontaneous
healing [2] and require intervention—surgical or otherwise—to
revive the healing process. What remains contentious is the time
point at which a non-healing fracture can be termed a nonunion. A
survey of 335 practicing orthopedic surgeons [2] reported that
surgeons deﬁne nonunion at a range of fracture ages, but there was
a mode at 3 months and a second mode at 6 months.
A nonunion can unite when adequate stability is provided in an
osteogenic environment. These conditions are generally achieved
by operative means, including some form of bone ﬁxation to
provide adequate stability, decortication of bone ends, and
application of bone graft material to enhance healing capacity
[3]. Depending on nonunion location and the type of revision
surgery, the success rate ranges from 68% to 96% [4]. However,
revision surgery for established nonunions is technically difﬁcult
and carries risk of complications. Certain conditions at the
nonunion site render operative intervention inevitable (e.g., gross
instability, malalignment, or limb-length discrepancy). When
surgery is optional, more conservative modalities have been
proposed to promote healing and avoid potential risks of revision
surgery [5–8]. Among such options, low-intensity pulsed ultra-
sound (LIPUS) has been evaluated in clinical studies, and has
demonstrated a positive effect on delayed unions and nonunions
[6,9–18].
We undertook a systematic literature review and meta-analysis
to obtain a summary estimate of effect size for the heal rate
following LIPUS treatment of delayed unions and nonunions. We
also sought to assess any factors that could affect the results of
LIPUS treatment of delayed unions and nonunions.
Methods
This systematic review of the literature and meta-analysis
adhered to the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines [19,20].
Eligibility criteria and literature search
Eligibility criteria were deﬁned before a comprehensive search
of the relevant literature. Studies were considered eligible if they
met the following inclusion criteria:
 LIPUS was used as an alternative to surgery for non-healing
fractures.
 LIPUS treatment was applied at least 3 months after the last
surgical procedure.
 At least one outcome of interest was provided (Heal/Fail).
 A clear deﬁnition of delayed union or nonunion was included.
The following exclusion criteria were used:
 Experimental and animal studies.
 Review papers, case reports, and letters to editors.
 Papers dealing with fresh fractures (less than 3 months old).
 Papers with fewer than 12 patients.
An electronic search of the MedLine database via the PubMed
search machine was initially undertaken using the following
search strategy: (((ultrasound[All Fields] AND bone[All Fields] AND
stimulation[All Fields]) OR LIPUS[All Fields] OR PLIUS[All Fields]
OR EXOGEN[All Fields] OR SAFHS[All Fields]) OR (Low[All Fields]
AND Intensity[All Fields] AND pulsed[All Fields] AND(“ultrasonography”[Subheading] OR “ultrasonography”[All Fields]
OR “ultrasound”[All Fields] OR “ultrasonography”[MeSH Terms]
OR “ultrasound”[All Fields] OR “ultrasonic”[MeSH Terms] OR
“ultrasonics”[All Fields])))
The search was further extended to the Ovid MEDLINE, CINAHL,
AMED, EMBASE, Cochrane Library, and Scopus databases. No
language restrictions were imposed. Manual searches were done of
the reference section of 10 recent LIPUS reviews [6,10–18], to yield
articles that might have been missed, and co-authors contributed
articles that might still have been missed. Reviewers indepen-
dently assessed titles and abstracts of the retrieved articles. The full
text was obtained for potentially eligible articles and evaluated
against eligibility criteria. Disagreement between reviewers was
resolved by discussion. Demographic and baseline characteristics
and outcome data were extracted from eligible papers and
tabulated in a predeﬁned spreadsheet. Titles of journals, names
of authors, and institutions were not masked to avoid duplication.
Quality assessment
The methodological quality of the primary studies was
evaluated with the Methodological Index for Non-Randomized
Studies (MINORS) [21]. This instrument consists of eight method-
ological items for non-randomized studies, each receiving a
maximum of 2 points, so the ideal score is 16 for non-randomized
studies. Each primary study was assigned a score independently by
two reviewers [CP, PVG]. Studies were also evaluated by these
assessors with a level of evidence rating [22]. Disagreements were
resolved by consensus.
Statistics
The main outcome of interest (heal rate) was a proportion.
Binary outcomes were expressed as odds ratios with 95%
conﬁdence intervals (CIs). Heterogeneity was assessed using
Cochran x2 test and Higgin’s I2 statistic [23,24]. Heterogeneity
was considered signiﬁcant at p < 0.1, while an I2 value greater than
50% was thought to represent signiﬁcant heterogeneity. Pooling of
proportions was done with OpenMeta[Analyst] software (accessed
at www.cebm.brown.edu/openmeta) using the DerSimonian and
Laird random effects model. For binary data (expressed as odds
ratios) the Mantel-Haenszel statistical method was used with
either ﬁxed or random effects, depending on the degree of
statistical heterogeneity present (when I2 was above 50, a random
effects model was used). RevMan (5.3) software (Review Manager,
Nordic Cochrane Centre, Copenhagen, Denmark) was used to
process binary data, produce pooled estimates of effect size, and
test for presence of statistical heterogeneity. Comparison of heal
rates between two groups was conducted with the Wilcoxon rank
sum test.
Subgroup analysis
Subgroups were decided a priori based on anatomic location of
the nonunion. Additional sub-groups were created based on
factors that were thought to potentially impact treatment,
including patient age, smoking status, fracture age, prior-with-
out-surgery-interval (PWSI, deﬁned as the time elapsed from the
last surgical procedure until the commencement of LIPUS
treatment), and number of prior surgeries.
Sensitivity analysis
We planned a priori to repeat our analysis after excluding
studies of dubious eligibility, poor methodological quality, or
outlying results. Conﬁdence in the robustness of our ﬁndings
Fig. 1. Flowchart of the search process.
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results compared with those of the original analysis.
Results
Search process
A total of 4611 references were evaluated (Fig. 1) to yield 10
eligible references on LIPUS treatment of human fracture
nonunions [4,9,25–32]. Three references [33–35] were obtained
outside the scope of the PubMed search, while 4608 references
were found by PubMed. Two references that emerged in the
PubMed search were excluded because they reported a registry
[36,37]; both papers were superseded by a recent report about the
same registry that included more patients and had fewer
methodological ﬂaws, but did not appear in the PubMed search
[35]. Most references excluded from meta-analysis did not report
on human bone fractures (Fig. 1). The treatment group of a
randomized controlled trial (RCT) dealing with tibial delayed
unions treated with either LIPUS or sham device [29] was used as a
prospective cohort, and only data related to LIPUS were extracted
for the pooled analysis.
A range of different deﬁnitions of fracture nonunion were used
by authors of primary studies. All deﬁnitions were similar in that
nonunion was deﬁned as diagnosable at no less than 3 months
post-fracture, and all deﬁnitions required radiological conﬁrma-
tion.
Tables 1–3 list basic demographic and baseline characteristics
as well as follow-up details of component studies. All data reﬂect
the potential presence of clinical diversity across included studies.
Publication bias
We did not set any language restriction during the search
process. In addition, we evaluated publication bias by generating
funnel plots for the outcomes of interest. The distributions of data
points within the funnel plots were symmetrical, indicating that
publication bias was unlikely (Fig. 2).
Quality assessment
MINORS scores ranged from 5 to 12 (mean: 8.7, median: 9)
across primary studies (Table 3). The only RCT was rated as a
prospective study, but only one arm of this study (treatment group)
was used as a prospective cohort of cases [29]. More than half of
the primary studies were Level II (Table 3).
Overall heal rate (all anatomical sites)
All 13 component studies (1441 nonunions) provided relevant
data. The fracture age (time interval from fracture occurrence to
commencement of LIPUS treatment) across all primary studies was
at least 3 months. Three studies [26,34,35] included some patients
who received an operative intervention within 3 months of
commencement of LIPUS treatment, so the PWSI was <3 months.
In order to avoid bias (contribution of the recent surgery to the ﬁnal
outcome) such cases were excluded from the pooled analyses. The
pooled estimate of effect size for the heal rate, for any anatomical
site of the nonunion and fracture age of at least 3 months was 82%
(95% CI: 77–87%). Signiﬁcant statistical heterogeneity was detected
across primary studies (Q = 41.2 (df = 12), p < 0.001, Tau2 = 0.006,
I2 = 71) (Fig. 3). Considering a stricter deﬁnition of nonunion as
fracture age of 8 months, the calculated pooled estimate of effect
size for the heal rate was 84% (95% CI: 77%–91.6%) and was derived
from 9 studies (239 participants). Again, signiﬁcant statisticalheterogeneity was present: Q = 21 (df = 8), p < 0.001, Tau2 = 0.007,
I2 = 62) (Fig. 4).
Subgroup analysis
We investigated the potential effect of patient age, fracture age,
smoking habit, gender, type of nonunion, PWSI, and number of
prior surgeries on outcome. Only type of nonunion and PWSI
seemed to have an impact on ﬁnal outcome. The odds of healing
were twice as large in hypertrophic nonunions, compared to
Table 1
Demographic and baseline characteristics of included studies.
Study Year Study type Period of
study
Study
N
Male:
Female
Patient age yrs, mean
(range)
Bone Criterion for deﬁning
nonunion
Fracture ave. age, months
(range)
Nolte
et al.
2001 P, multi-
center
1995–1997 28 16:12 47 (18–90) Mix of bones 6 mo 14.2
(5.8–32)
Mayr
et al.
2002 P 1995–1999 100 63:37 44  2 Mix of bones 8 mo
(nonunion), 4 mo
(delayed)
11.6  2.4
Lerner
et al.
2004 R 1997–2001 17 14:3 32.7
(19–63)
Mix of long
bones
6 mo? 11
(1–40)a
Pigozzi
et al.
2004 P 2000–2002 15 12:3 35.5  12.9 (18–60) Mix of bones 9 mo 11  2
Gebauer
et al.
2005 P 1995–1997 66 40:26 46  1.9
(14–86)
Mix of bones 8 mo 39  6.2
(8–198)
Jingushi
et al.
2007 P, multi-
center
nr 72 52:20 40.4
(14–83)
Mix of long
bones
3 mo 18.9
(3–159)
Rutten
et al.
2007 P, multi-
center
2000–2003 71 56:15 40
(17–89)
Tibia 6 mo 8.4  0.48 (6–25.7)
Hemery
et al.
2010 R 2006–2008 14 11:3 39
(16–62)
Tibia/Femur 6 mo  6
Schofer
et al.
2010 RCT, multi-
center
2002–2005 51 36:15 42.6  14.6 Tibia 4 mo
(del un)
14
(all >4 mo)
Roussignol
et al.
2012 R 2004–2009 60 42:17 43
(17–85)
Mix of bones 6 mo 9
(5.4–45.8)
Watanabe
et al
2013 R, cohort 1998–2007 151 110: 41 36.3
(16–82)
Mix of long
bones
3mo
(delayed) 6 mo
(nonunion)
NR
Farkash
et al
2015 R 2011–2013 29b 29:0 (18–34) Scaphoid 3 mo 7
(3–12)
Zura
et al.
2015 R, cohort 1994–1998 767c 408: 359 45.8 [SD,16.5] Mix of bones 12mo 30 [SD:31.5]
Prospective, R: retrospective, RCT: randomized control trial, NR: not reported, M: male, F: female, frx age: fracture age (time interval from the occurrence of fracture till the
start of LIPUS treatment), SD: standard deviation.
a Two cases were excluded from the pooled analysis, as respective fracture age was <3 months.
b A group of 13 cases was excluded from the ﬁnal analysis as it represented in essence fresh scaphoid fractures diagnosed within 17 days from injury and treated
conservatively for 3 months before commencing LIPUS treatment.
c A subgroup of 91 cases with PWSI  3 mo included in pooled analysis.
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with a more favorable result (Fig. 6).
We further stratiﬁed nonunions by anatomical site and
calculated heal rate (Table 4). No statistically signiﬁcant difference
was detected between upper and lower extremity long bone
nonunions in heal rate (Table 5).
Sensitivity analysis
We repeated the pooled analysis after excluding studies that
were regarded as weaker in methodological quality [26,30,34,35].
These studies had been assigned a score 6 in the MINORS scale.
We also repeated the pooled analysis after excluding the study by
Pigozzi [33], as it did not accurately report the PWSI. All above
procedures did not substantially change results compared with the
original procedure (Table 6).
Discussion
These ﬁndings indicate that LIPUS for nonunions can result in
an increased heal rate, particularly when treatment was done
within 3 to 6 months of the last revision surgery. Hypertrophic
nonunions seemed to beneﬁt more than biologically inactive
atrophic nonunions. Almost one-third of the primary studies were
assigned a low quality score, while the rating of the remainder was
moderate in quality. The moderate rating was a result of
retrospective study design, inadequate description of follow-up
methodology, patient drop-outs and losses to follow-up, or lack of
power analysis and sample size calculations in the primary studies.Nevertheless, we believe our included studies constitute the best
available material relevant to our review question.
Study limitations
Systematic reviews of the literature and meta-analyses provide
the strongest scientiﬁc evidence when they pool data from high
quality RCTs [38]. Unfortunately, this was not possible, so we had to
rely on data extracted from observational studies.
There are several reasons that RCTs relevant to our research
question are lacking. First, there is no sense that clinical equipoise
exists in comparing surgery to other nonunion treatments; rather,
it is assumed that surgery is required as ﬁrst-line treatment [39].
Without perceived equipoise, surgeons are reluctant to undertake
an RCT treating nonunion without surgery and Institutional Review
Boards may be reluctant to approve such an RCT. Second, patient
recruitment for an operative versus non-operative treatment
protocol has been difﬁcult in most countries, so it would take a
long time to recruit enough patients to achieve reasonable
statistical power. Third, there are standardized procedures for
surgical debridement, but ﬁxation, bone grafting, and post-
operative patient management are surgeon and/or institution
speciﬁc. This makes it hard to adequately control an RCT to
evaluate LIPUS. Fourth, surgery is hard to blind [40,41], which
makes it challenging to objectively assess outcomes. Fifth, once an
intervention is recognized as useful, there may be little impetus to
characterize exactly how useful it is [42]. Mayr proposed a
prospective, placebo-controlled trial of LIPUS but his proposal was
rejected; study authors were forced instead to do a prospective,
consecutive-observation study [25]. It is our hope that this meta-
Table 2
Baseline characteristics of component studies and potential sources of clinical diversity.
Study Prior without surgery interval
(PWSI), mo
Initial
treatment
Type of nonunion Smoking habit Prior surgeries, mean
(range)
Previous history of
infection
Cons Oper Atrophic Hypert Active
smokers
Non
smokers
Nolte et al. 12
(3.5–32)
8/29 21/
29
17/29 12/29 11/29 18/29 1.52
(06)
2/29
Mayr et al. 3 mo NR NR 84/100 16/100 28/89 61/89 NR 0/100
Lerner et al. 11
(1–40)a
0/18 18/
18
NR NR NR NR NR NR
Pigozzi et al. NR 7/15 8/15 NR NR NR NR 0.6
(0–2)
NR
Gebauer et al. 24.2  4.9
(4–197)
6/63 57/
63
35/46 11/46 23/64 41/64 1.6
(0–7)
0/67
Jingushi et al. 11.5
(3–68)
0/72 72/
72
32/72 40/72 NR NR 1.7
(1–8)
10/72
Rutten et al. 6.4
(3–23.6)
18/72 53/
71
54/71 17/71 24/55 31/55 1.2
(0–5)
3/71
Hemery et al. 12
(6–38)
0/14 14/
14
3/14 11/14 NR NR 1.7
(1–3)
6/14
Schofer et al. 4 mo 0/51 51/
51
NR NR 19/51 32/51 2 0/51
Roussignol
et al.
> 6 mo 0/60 60/
60
58/59 1/59 17/59 42/59 1.7
(1–4)
NR
Watanabe
et al
Delayed 3.6
(3–6)
Nonunion: 9.3 (6–32)
17/
151
134/
151
95/151 56/101 97/151 54/101 NR NR
Farkash et al 3 mob 29/29 0/29 NA NA NR NR 0 0/16
Zura et al. 3 mo c 88/
767
679/
767
NR NR 593/
767
174/
764
3.1  2.3 (SD) NR
Atr.: atrophic, Hypert: hypertrophic, NR: not reported, NA: not applicable (scaphoid).
a Cases with PWSI <3 months excluded from the pooled analysis.
b 13 cases excluded from the ﬁnal analysis as they were fresh scaphoid fractures diagnosed within 17 days from injury and treated conservatively for 3 months before
commencing LIPUS treatment.
c A subgroup of 91 cases with PWSI 3 mo included in pooled analysis.
Table 3
Treatment details, follow-up characteristics, and methodological quality of studies.
Study Ultrasound device/Daily stimulation
time
Duration of LIPUS treatment,
mo
mean
(range)
Follow-up, mean (duration)
mo
Drop out
rate
MINORS
rate
Level of evidence
Nolte et al. Exogen
20 min
5 mo
(1.7–13)
NR 29.2% 9 II
Mayr et al. Exogen
20 min
5.1 mo NR 17.3% 10 II
Lerner et al. Exogen
20 min
6.6mo
(3–12)
52 mo
(15–72)
5.8% 6 IV
Pigozzi et al. Exogen
20 min
3.1 mo
(1.6–4.6)
(4.6–5.8) mo 0 10 II
Gebauer
et al.
Exogen
20 min
4.7  0.3mo 13.2  0.68 mo 5.9% 12 II
Jingushi
et al.
NR 7.9 mo
(2–21)
NR NR 8 II
Rutten et al. Exogen
20 min
6.2 mo
(1.7–24.3)
32.4 mo
(13.2–55.2)
0 10 II
Hemery
et al.
Exogen
20 min
3mo NR 0 6 IV
Schofer
et al.
Exogen
20 min
3.7 mo 4 mo 9.8% 11 II
Roussignol
et al.
Exogen
20 min
5 mo
(3–8)
6 mo 1.6% 9 III
Watanabe et al Exogen
20 min
NR 12 mo 0 11 III
Farkash
et al
Melmak
20 min
2.3mo (1–4) NR 0 5 IV
Zura et al. Exogen
20 min
5.9 mo [SD,4.2mo] NR 40.3% 6 III
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Fig. 2. Funnel plot of heal rate between hypertrophic and atrophic nonunions.
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LIPUS versus surgery.
Although we performed a comprehensive search of published
literature without language restrictions, we acknowledge that
possible errors in search strategy and failure to include unpub-
lished reports could have resulted in missing data. However, we are
conﬁdent we did not miss large reports that could have biased our
estimate of effect size for several reasons. First, our results seem
free of publication bias, as indicated by the relative symmetry of
the respective funnel plot (Fig. 2). Second, other estimates based on
binary data were also free of statistical heterogeneity. Finally,
funnel plots of the intervention effect of binary outcomes against
study size were uniformly symmetrical, suggesting it is unlikely we
missed studies that would have had a statistically signiﬁcant effect.Fig. 3. Forest plot of heal rate Results of analysis
Favorable results of LIPUS intervention were obtained when
LIPUS was used as an alternative rather than an adjuvant to
surgery. Our results suggest that nonunions that present within 3
to 6 months of fracture are candidates for LIPUS treatment.
Biologically active nonunions beneﬁt more from application of
LIPUS that do atrophic nonunions (Fig. 5). This is of interest
because it is a common belief that the failure of hypertrophic
nonunions to heal is due to mechanical instability [43]. A common
surgical strategy to solve this problem is therefore revision of
ﬁxation without biological stimulation. Whether and how LIPUS
promotes bone healing in a hypertrophic environment, without
addressing mechanical instability, remains obscure. Of interest,
patient age, patient gender, smoking habit, fracture age, andacross all primary studies.
Fig. 4. Forest plot of heal rate across primary studies where nonunion was deﬁned at 8 months.
Fig. 5. Forest plot of comparison of hypertrophic vs atrophic nonunions in terms of heal rate.
Fig. 6. Forest plot of heal rate according to prior without surgery interval (PWSI).
Table 4
Heal rates per anatomical site (subgroup analysis).
Fracture site Number of references Patient N Heal Rate (Weighted mean)[a] 95% CI Heterogeneity
Tibia 10 354 86% 79%–93% Q = 47, df = 9, p < 0.001, I2 = 81
Femur 9 110 80.4% 70.6%–90.3% Q = 14, df = 8, p = 0.08, I2 = 42.6
Scaphoid 6 61 78% 62.6%–93.5% Q = 16, df = 5, p = 0.007, I2 = 68.5
Humerus 6 44 74% 61.4%–86% Q = 4, df = 5, p = 0.54, I2 = 0
Radius + Ulna 5 18 77.5% 60%–95% Q = 0.096, df = 4, p = 0.99, I2 = 0
a DerSimonian and Laird, random effect model.
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it should be appreciated that PWSI 3 months was used as aprerequisite of eligibility, to avoid bias from concurrent use of
surgery [4,25,27–29,31–34]. This provides evidence that LIPUS can
Table 5
Comparison of heal rates of long bones in upper and lower extremities (subgroup
analysis).
Fracture site N HR (95% CI) Median p*
Tibia 354 86%
(79%–93%)
87% Tibia vs humerus: p = 0.3
Humerus 44 74%
61.4%–86%
75% Humerus vs femur: p = 0.3
Radius + Ulna 18 77.5%
60%–95%
100% Tibia vs radius + ulna: p = 0.09
Femur 110 80.4%
70.6%–90.3%
92% Femur vs radius + ulna: p = 0.19
* Wilcoxon rank sum test.
Tab
Res
F
A
E
A
*
a
b
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we cannot recommend LIPUS instead of surgery for all nonunions.
Such a recommendation could only be made in the context of an
RCT comparing LIPUS to surgery.
LIPUS was used as an adjunct to surgery in several studies
reported here [9,26]. Initial treatment was conservative in 8 cases
and operative in 21 cases, with additional treatments including
bone grafting, reosteosynthesis, and other surgeries an average of
52 weeks prior to LIPUS [9]. While this study has the limitation
that surgery could bias the results of LIPUS treatment, it supports
the view that addition of LIPUS to surgical treatment can be
helpful. Because data on LIPUS used as an adjunct to surgery is
scarce, no strong recommendation can be made for adjunctive
LUPUS [35].
Overall, LIPUS may be useful in patients for whom surgery is
high risk. For example, surgery is not recommended for patients at
risk of delirium due to old age, or patients with dementia, extreme
hypertension, extensive soft-tissue trauma, mechanical ventila-
tion, metabolic acidosis, multiple organ failure, or coma [44].
Avoidance of surgery in such patients may mean that non-surgical
techniques such as LIPUS are especially valuable.
Conclusions
This systematic review and meta-analysis is supportive of the
use of LIPUS in patients with a nonunion. Results are better in
biologically active nonunions and when the modality is applied 3–
6 months after the last revision surgery. Given an overall average
success rate for LIPUS of better than 80% this rivals the success of
surgical treatment of non-infected nonunions. An RCT of LIPUS
versus surgery should be conducted so surgeons will be able to
compare the success of surgical treatment with LIPUS treatment
for nonunions.le 6
ults of the sensitivity analysis.
racture site N of studies 
ll studies All 13 
xclusion of low quality studies 9 [a] 
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